Bausch Health Q3 2026 net income more than doubles to $446 million
BHC•Bausch Health reported third-quarter 2026 net income of $446 million, more than double a year earlier, as revenue rose 10% to $2.94 billion. It forecast full-year revenue of $10.98 billion to $11.18 billion and authorized a $50 million share repurchase program.
1. Quarterly results
Bausch Health’s diluted earnings per share more than doubled year over year to $1.15, while cash provided by operating activities more than doubled to $813 million. The board authorized a $50 million share repurchase program to offset dilution from management equity awards expected to vest in 2027.
